Literature DB >> 3280038

Activation of the complement system at the interface between blood and artificial surfaces.

M D Kazatchkine1, M P Carreno.   

Abstract

The interaction between blood and the artificial devices used in haemodialysis results in the activation of the immune system. Complement activation is known to play a key role in the production of inflammatory mediators. This article describes the complement system and the way in which it is triggered in the patient undergoing haemodialysis. It highlights those factors thought to be of particular importance in the pathogenesis of adverse reactions and targets them as obstacles to be overcome in the future design of biocompatible materials.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280038     DOI: 10.1016/0142-9612(88)90066-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  In vitro complement activation after contact with pyrolytic carbon-coated and uncoated polyethylene terephthalate.

Authors:  E Cenni; D Granchi; G Ciapetti; S Stea; E Verri; S Gamberini; A Gori; A Pizzoferrato; P Zucchelli
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

2.  A stimulus-responsive contrast agent for ultrasound molecular imaging.

Authors:  Mark A Borden; Hua Zhang; Robert J Gillies; Paul A Dayton; Katherine W Ferrara
Journal:  Biomaterials       Date:  2007-10-30       Impact factor: 12.479

3.  Activation of complement during apheresis.

Authors:  G Hetland; T E Mollnes; P Garred
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

4.  Fc microparticles can modulate the physical extent and magnitude of complement activity.

Authors:  Brandon Alexander Holt; Michael C Bellavia; Daniel Potter; David White; Sean R Stowell; Todd Sulchek
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

5.  Complement C3 participation in monocyte adhesion to different surfaces.

Authors:  A K McNally; J M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

6.  Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.

Authors:  G V Ullio Gamboa; S D Palma; A Lifschitz; M Ballent; C Lanusse; C Passirani; J P Benoit; D A Allemandi
Journal:  Parasitol Res       Date:  2016-02-06       Impact factor: 2.289

7.  Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.

Authors:  Isabelle Bertholon; Christine Vauthier; Denis Labarre
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 8.  Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs.

Authors:  Mark Y Chan; Jeffrey I Weitz; Yahye Merhi; Robert A Harrington; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2009-10       Impact factor: 2.300

9.  The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.

Authors:  G Borchard; J Kreuter
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

Review 10.  Complement activation and cardiac surgery: a novel target for improving outcomes.

Authors:  Gregory L Stahl; Stanton K Shernan; Peter K Smith; Jerrold H Levy
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.